OLK
Olink Holding AB ADR
NASDAQ: OLK · HEALTHCARE · DIAGNOSTICS & RESEARCH
$26.08
+0.00% today
Updated 2026-06-03
Market cap
$3.24B
P/E ratio
—
P/S ratio
18.98x
EPS (TTM)
$-0.27
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
WallStSmart proprietary scores
19
out of 100
Grade: F
Strong Sell
Investment rating
6.0
Growth
B8.0
Quality
A2.0
Profitability
F4.0
Valuation
C1/9
Piotroski F-Score
Weak
3.2
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$26.00
-0.31%
12-Month target
—
—
Intrinsic (DCF)
$18.02
Margin of safety
-44.73%
Price chart
Stock snapshot
Strengths
+ Altman Z 3.20 — safe zone
+ Debt/equity 0.06x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at -19.70%
- Negative free cash flow $-8.24M
- 44.73% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2020 | 2021 | 2022 | 2023 | TTM |
|---|---|---|---|---|---|
| Revenue | $54.07M | $94.97M | $139.85M | $169.91M | $170.89M |
| Net income | $-6.78M | $-38.34M | $-12.85M | $-31.66M | $-15.97M |
| EPS | — | — | — | — | $-0.27 |
| Free cash flow | $-18.04M | $-68.49M | $-38.62M | $-51.34M | $-8.24M |
| Profit margin | -12.54% | -40.37% | -9.19% | -18.63% | -19.70% |
Peer comparison
Smart narrative
Olink Holding AB ADR trades at $26.08. Our Smart Value Score of 19/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 3.20, it sits in the safe zone. TTM revenue stands at $170.89M. with profit margins at -19.70%. Our DCF model estimates intrinsic value at $18.02.
Frequently asked questions
What is Olink Holding AB ADR's stock price?
Olink Holding AB ADR (OLK) trades at $26.08, on a P/S of 19.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Olink Holding AB ADR overvalued?
Olink Holding AB ADR carries a Smart Value Score of 19/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $18.02 against the $26.08 price, so on cash flow terms the market is paying a premium for Olink Holding AB ADR's growth. The Strong Sell rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Olink Holding AB ADR (OLK)?
The 12-month analyst consensus target is $26.00, about 0.3% below the current $26.08. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Olink Holding AB ADR (OLK)?
Our DCF model estimates intrinsic value at $18.02, a -44.7% margin of safety versus today's $26.08. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Olink Holding AB ADR's revenue?
Olink Holding AB ADR's trailing twelve-month revenue is $170.89M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Olink Holding AB ADR's Altman Z-Score is 3.20, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio18.98x
ROE-7.03%
Beta0.52
50D MA$24.51
200D MA$24.02
Shares out0.12B
Float0.04B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—